SEC Form 4 · accession 0000899866-15-000142
ALEXION PHARMACEUTICALS, INC. · ALXN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John B Moriarty
Officer — EVP & General Counsel
Period of report
Aug 5, 2015
Accepted (ET)
Aug 5, 2015 · 6:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000899866
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $.0001 per share | Aug 5, 2015 | M | 10,000 | $92.65 | A | 42,428 | D | |
| Common Stock, par value $.0001 per shareF1 | Aug 5, 2015 | S | 6,574 | $198.12 | D | 35,854 | D | |
| Common Stock, par value $.0001 per shareF2 | Aug 5, 2015 | S | 3,436 | $199.05 | D | 32,418 | D | |
| Common Stock, par value $.0001 per share | Aug 5, 2015 | M | 10,000 | $92.65 | A | 42,418 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common Stock | $92.65 | Aug 5, 2015 | M | 10,000 | D | Dec 10, 2013 | Dec 10, 2022 | Common Stock, par value $.0001 per share | 10,000 | 45,000 | D |
Explanation of responses
- F1This transaction was executed in multiple trades through a broker-dealer at prices ranging from $197.63 - $198.62. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
- F2This transaction was executed in multiple trades through a broker-dealer at prices ranging from $198.63 - $199.62. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.